Patent classifications
C12R2001/145
MEDIUM COMPOSITION FOR PRODUCING ALCOHOL FROM SYNTHETIC GAS COMPRISING ETHANOL AND METHOD FOR PRODUCING ALCOHOL USING THE SAME
The present disclosure relates to a composition for preparing hexanol or butanol and a method for preparing hexanol or butanol using ethanol and synthesis gas, wherein the composition according to an aspect of the present disclosure is a medium composition containing ethanol as an active ingredient, and by culturing a strain producing hexanol or butanol after inoculating with a medium containing the composition and supplying synthesis gas, hexanol or butanol can be prepared economically using inexpensive synthesis gas, and hexanol or butanol can be prepared with high efficiency by focusing the flow of a carbon source consumed in a fermentation process to the production of hexanol or butanol.
Method for producing organic substance
Provided is a method which allows, for example, suppression of foaming in the purification step such as distillation and continuous operation, as well as direct treatment of a waste liquid (can liquid) without having to subject the same to an extra purification treatment by removing the microorganisms, nitrogen compounds, and phosphorous compounds at once from an organic substance-containing liquid obtained from microbial fermentation. Also disclosed is a method for producing an organic substance, comprising a microbial fermentation step, a separation step, a liquefaction step, and a second purification step, wherein the concentration of the nitrogen compound in the second can liquid is 0 to 150 ppm based on the total mass of the second can liquid, and the concentration of the phosphorous compound in the second can liquid is 0 to 5 ppm based on the total mass of the second can liquid.
RECOMBINANT MICROORGANISMS AND USES THEREFOR
The disclosure provides genetically engineered C1-fixing microorganisms capable of producing nanobodies. Additionally, the disclosure provides engineered microorganisms comprising one or more disrupted genes to strategically divert carbon flux away from nonessential or undesirable products towards products and/or co-products of interest. The disclosure enables co-production of useful chemicals from gaseous substrates.
PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
MICROORGANISMS AND METHODS FOR IMPROVED BIOLOGICAL PRODUCTION OF ETHYLENE GLYCOL
The disclosure provides genetically engineered microorganisms and methods for improved biological production of ethylene glycol and precursors of ethylene glycol. The microorganism of the disclosure produces ethylene glycol or a precursor of ethylene glycol through one or more of 5,10-methylenetetrahydrofolate, oxaloacetate, citrate, malate, and glycine. The disclosure further provides compositions comprising ethylene glycol or polymers of ethylene glycol such as polyethylene terephthalate.
Starch aqueous fermentation feedstock and a method for the production thereo
Provided are aqueous fermentation feedstocks comprising glucose monomers at a concentration of less than 50 gram/Liter (g/L) of the total feedstock, water-soluble dextrose oligomers at a concentration in a range between 50 g/L and 300 g/L of the total feedstock; and water. Further provided are methods of production thereof and uses thereof in the production of single cell protein and/or ethanol.
METHOD OF CONTROLLING GAS FERMENTATION PLATFORM FOR IMPROVED CONVERSION OF CARBON DIOXIDE INTO PRODUCTS
Methods and systems to control flexible gas fermentation platforms for improved conversion of CO.sub.2 into products is developed and particularly relates to a control process and system to control a ratio of feedstock gases and maximize the concentration of inert components in a bioreactor tail gas stream and or bioreactor headspace. Improved carbon utilization results though providing the most beneficial ratio of substrates to the bioreactor of the fermentation process.
INTERMITTENT FEEDSTOCK TO GAS FERMENTATION
The disclosure provides methods to improve the economics of the gas fermentation process. A fermentation process is integrated with an industrial or syngas process and an reverse water gas shift process. An intermittent supply of reverse water gas shift process feedstock from the reverse water gas shift process is provided to the bioreactor for fermentation. The reverse water gas shift process feedstock may supplement or partially displace the C1 feedstock from the industrial or syngas process. Whether the reverse water gas shift process feedstock supplements or displaces the C1 feedstock may be based upon a function of the cost per unit of the C1 feedstock, the cost per unit of the reverse water gas shift process feedstock, and the value per unit of the fermentation product, or may depend upon the target gas ratio of the feedstock to the gas fermentation process.
FLEXIBLE FERMENTATION PLATFORM FOR IMPROVED CONVERSION OF CARBON DIOXIDE INTO PRODUCTS
An integrated process and system for the production of at least one gas fermentation product from a gaseous stream has been developed. The disclosure provides improved carbon utilization through both the recycle of a bioreactor tail gas via various different flow schemes and the employment of a CO.sub.2 to CO conversion system such as a reverse water gas shift unit. Recycling of the bioreactor tail gas and employment of a CO.sub.2 to CO conversion process provides for favourable H.sub.2:CO molar ratios of the feed to the gas fermentation bioreactor(s) for enhanced production of fermentation products. Bypass embodiments provide for optimal sizing of the reverse water gas shift unit to minimize cost.
Use of Faecalibacterium prausnitzii in preparation of medicine for treating pathological ventricular remodeling and/or heart failure following myocardial infarction
The present disclosure belongs to the technical field of biomedicine, and provides use of Faecalibacterium prausnitzii in preparation of a medicine for treating pathological ventricular remodeling and/or heart failure following myocardial infarction. The Faecalibacterium prausnitzii can improve pathological ventricular remodeling and/or heart failure caused by myocardial infarction in experimental animals, resume the systolic function, reduce the cardiac fibrosis, and inhibit the pathological myocardial hypertrophy of mice with myocardial infarction. Furthermore, the inactivated Faecalibacterium prausnitzii has no such improvement effect.